Lymphoma Follow-up

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00744120
Recruitment Status : Completed
First Posted : August 29, 2008
Last Update Posted : December 20, 2013
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )

Brief Summary:
This follow-up protocol is designed to evaluate participants who have previously been lymphoma patients treated on approved clinical studies of the National Institutes of Health.

Condition or disease

Detailed Description:

The intent of this protocol is to accrue up to 800 volunteers who are interested in participating in NIA research studies as part of follow-up for previous cancer treatment at NIH. Participants will be asked to answer questions regarding their general health status, diagnoses, and admissions to hospital, and to provide possible documentation. They may be asked to come to the NIA Clinical Research Unit at Harbor Hospital to participate in a follow-up evaluation. They will have the opportunity to obtain additional information about studies in which they may wish to participate and to discuss eligibility issues with NIA staff members. Any identified clinical problems in need of care will also be discussed. Volunteers may be referred, with their permission, to their private medical doctor for follow-up. They may be re-evaluated within a year for further follow-up.

The follow-up evaluation may include history and physical, blood and urine tests, questionnaire, MRI or CT.

Study Type : Observational
Actual Enrollment : 51 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Lymphoma Follow-up Protocol
Study Start Date : October 2003
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lymphoma
U.S. FDA Resources

Primary Outcome Measures :
  1. Long-term survival following treatment for lymphoma [ Time Frame: Annually ]

Secondary Outcome Measures :
  1. Long-term toxicity possibly attributable to lymphoma or treatment for lymphoma [ Time Frame: Annually ]

Biospecimen Retention:   Samples Without DNA
Blood serum

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients, previously entered on NIH study who may be eligible if they have rare, unusual, interesting or unknown conditions that require diagnosis

Inclusion Criteria:

  • Previously treated on an approved NCI/NIH protocols
  • Willing and able to provide informed consent for current NIA protocol
  • Rare, unusual, interesting or unknown condition that requires diagnosis

Exclusion Criteria:

  • Does not meet the criteria of any previously-approved NIH Protocol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00744120

United States, Maryland
NIA Clinical Research Unit
Baltimore, Maryland, United States, 21225
Sponsors and Collaborators
National Institute on Aging (NIA)
Principal Investigator: Patricia L. Duffey, RN National Institute on Aging (NIA)

Responsible Party: National Institute on Aging (NIA) Identifier: NCT00744120     History of Changes
Other Study ID Numbers: AG0108
First Posted: August 29, 2008    Key Record Dates
Last Update Posted: December 20, 2013
Last Verified: December 2013

Keywords provided by National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) ):

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases